Showing 2766 results
- Story /
Researchers around the world are collaborating to provide solutions to immediate and future challenges.
- Story /
Christine Hà lost her vision at a young age – and went on to become an award-winning chef.
- Story /
- Story /
The majority of Europeans can’t identify the warning signs of heart failure, a life threatening disease, which affects one in five people in the region.
- Story /
Compounds block a protein involved in many cancers by cementing it shut.
- Story /
This is the story of how three Novartis colleagues took a career decision to improve health in lower income countries.
- Story /
Novartis researchers use automation to rapidly identify starting points for new drugs.
- Media Release /New approvals are based on JUNIPERA trial data showing Cosentyx® (secukinumab) demonstrated reduced flare risk versus placebo and improvement in disease activity observed over two years across both…
- Key Release /Ad hoc announcement pursuant to Art. 53 LR With two maintenance doses a year, Leqvio is the first and only FDA-approved small interfering RNA (siRNA) therapy for LDL-C (bad cholesterol…
- Media Release /There are no currently approved therapies impacting disease progression for the up to 8 million people suffering from geographic atrophy (GA)1,2 Acquisition will add GT005 to the Novartis portfolio…
Pagination
- ‹ Previous page
- 1
- …
- 121
- 122
- 123
- 124
- 125
- 126
- 127
- …
- 277
- › Next page